89bio, Inc. / Fundamentals
Income statement
- Net revenue
€18.12K - Cost of goods sold
€6.90K - Gross profit
€11.22K - SG&A expenses
€38.52M - R&D expenses
€363.37M - EBITDA
-€392.79M - D&A
-€3.00M - EBIT
-€401.90M - Interest expenses
€2.95M - EBT
-€387.38M - Tax expenses
€929.49K - Net income
-€388.54M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€11.51M - Changes in working capital
-€1.57M - Operating cash flow
-€378.96M - Capex
€62.14K - Other investing cash flow
€12.08M - Net investing cash flow
-€89.13M - Total cash dividends paid
€0.00 - Issuance of common stock
€368.90M - Debt repayment
€8.07M - Other financing cash flow
€252.11M - Net financing cash flow
€396.33M - Foreign exchange effects
€0.00 - Net change in cash
-€71.75M - Cash at end of period
€111.40M - Free cash flow
-€378.90M
Balance sheet
- Cash and cash equivalents
€111.40M - Cash and short-term investments
€484.30M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€34.83M - Total current assets
€519.13M - Property, plant & equipment
€1.15M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€545.44K - Total non-current assets
€1.70M - Total assets
€520.83M - Accounts payable
€12.65M - Short-term debt
€676.62K - Other current liabilities
€20.86M - Total current liabilities
€34.19M - Long-term debt
€586.00K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€35.78M - Total non-current liabilities
€36.37M - Total liabilities
€70.55M - Common stock
€127.73K - Retained earnings
-€869.33M - Other equity
€105.29K - Total equity
€450.27M - Total liabilities and shareholders' equity
€520.83M
Company information
- Market capitalization
€1.23B - Employees
93 - Enterprise Value
€1.15B
Company ratios
- Gross margin
-
61.9% Much better than peer group: -667,933.7% - EBITDA margin
-
-2,167,281.0% Much worse than peer group: -10,930.6% - EBIT margin
-
-2,217,504.8% Much worse than peer group: -11,493.3% - EBT margin
-
-2,137,404.8% Much worse than peer group: -11,860.7% - Net margin
-
-2,143,838.1% Much worse than peer group: -11,237.6% - ROE
-
-86.3% Much worse than peer group: -41.9% - ROA
-
-74.6% Better than peer group: -90.9% - Asset turnover
-
0.0% Worse than peer group: 13.3% - FCF margin
-
-2,091,300.0% Much worse than peer group: -8,558.2% - FCF yield
-30.9% - Efficiency ratio
2,167,381.0% - Net sales per employee
-
€194.88 - Net income per employee
-
-€4.18M